What it’s best to know:

– Inovalon, a supplier of cloud-based healthcare information analytics options, at this time introduced the acquisition of VigiLanz, a number one supplier of SaaS-based medical surveillance and affected person security software program.

– This acquisition underlines Inovalon's dedication to driving innovation and offering healthcare stakeholders with data-driven options. By integrating VigiLanz's experience, Inovalon goals to enhance affected person security, optimize healthcare prices and in the end enhance well being outcomes for all.

VigiLanz: a powerhouse in medical surveillance

Based in 2001, VigiLanz has established itself as a number one power in medical surveillance and affected person security software program. Their options assist hospitals, healthcare suppliers and life science firms determine and mitigate potential hurt, in the end bettering affected person outcomes and decreasing prices.

“For greater than 20 years, VigiLanz has put affected person security and well-being on the coronary heart of every part we do, and we’re proud to affix Inovalon to advance the care physicians can present, the general security of healthcare and proceed to enhance high quality of life. of the hundreds of thousands of sufferers they look after,” mentioned Dr. David Goldsteen, founder and CEO of VigiLanz. “It’s really thrilling to be a part of a corporation that’s as targeted as we’re on harnessing the ability of knowledge to enhance healthcare.”

Synergy and strategic progress

This acquisition brings a number of essential advantages to Inovalon:

• Enriched portfolio: VigiLanz options complement Inovalon's current providing and supply a complete package deal for medical surveillance and affected person security.
• In depth buyer base: The acquisition expands Inovalon's attain and opens doorways to new markets and buyer segments.
• Improved information connectivity: VigiLanz information belongings strengthen Inovalon's platform, enabling extra complete and insightful analyses.
• Market alternatives: The mixed entity may have entry to a considerably bigger addressable market, exceeding $340 million within the supplier section and $5.7 billion within the life sciences sector.

Impression and future prospects

This acquisition underscores Inovalon's dedication to enabling data-driven healthcare options that prioritize medical security and improved outcomes. By combining their experience and assets, Inovalon and VigiLanz purpose to:

• Cut back unwanted side effects: By proactively figuring out potential dangers, the mixed platform may help forestall hurt to sufferers and enhance security measures.
• Enhance affected person care: Improved medical surveillance allows earlier intervention and higher remedy selections, main to higher affected person outcomes.
• Decrease healthcare prices: By decreasing unwanted side effects and bettering the standard of care, the mixed platform can contribute to value financial savings throughout the healthcare ecosystem.

Monetary particulars in regards to the acquisition haven’t been disclosed.